• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    RxSight, Inc. - Common Stock (NQ:RXST)

    5.340 -0.280 (-4.98%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,361,380
    Open 5.550
    Bid (Size) 5.340 (300)
    Ask (Size) 5.900 (200)
    Prev. Close 5.620
    Today's Range 5.305 - 5.900
    52wk Range 4.480 - 13.36
    Shares Outstanding 33,981,877
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Law Offices of Howard G. Smith Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire

    Performance

    YTD
    -48.6%
    -48.6%
    1 Month
    +7.9%
    +7.9%
    3 Month
    -21.0%
    -21.0%
    6 Month
    -46.5%
    -46.5%
    1 Year
    -57.0%
    -57.0%

    More News

    Read More
    News headline image
    RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
    From RxSight, Inc.
    Via GlobeNewswire
    RxSight (NASDAQ:RXST) Q1 2026 Results: Revenue Beats but Loss Widens Amid Cautious Market Reaction ↗
    Via Chartmill
    RXSIGHT INC (NASDAQ:RXST) Reports Q4 Beat but Cautious 2026 Outlook Weighs on Shares ↗
    Via Chartmill
    News headline image
    RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    RxSight (RXST) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    RxSight, Inc. to Present at the Bank of America Healthcare Conference
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    RxSight (RXST) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    RxSight, Inc. Announces Chief Financial Officer Transition
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
    From RxSight, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill

    Frequently Asked Questions

    Is RxSight, Inc. - Common Stock publicly traded?
    Yes, RxSight, Inc. - Common Stock is publicly traded.
    What exchange does RxSight, Inc. - Common Stock trade on?
    RxSight, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for RxSight, Inc. - Common Stock?
    The ticker symbol for RxSight, Inc. - Common Stock is RXST on the Nasdaq Stock Market
    What is the current price of RxSight, Inc. - Common Stock?
    The current price of RxSight, Inc. - Common Stock is 5.340
    When was RxSight, Inc. - Common Stock last traded?
    The last trade of RxSight, Inc. - Common Stock was at 07/08/26 04:00 PM ET
    What is the market capitalization of RxSight, Inc. - Common Stock?
    The market capitalization of RxSight, Inc. - Common Stock is 181.46M
    How many shares of RxSight, Inc. - Common Stock are outstanding?
    RxSight, Inc. - Common Stock has 181M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.